T2D Clinical Trial
Official title:
Clinical Study on Exploring High Risk Factors Inducing the Progress of Diabetes
Explore the high related factors of impaired glucose tolerance through descriptive statistics and analysis of variance.
This study is a cross-sectional study planned to include healthy individuals with a BMI within the normal range (18.5<BMI<24 kg/m2) (HbA1c ≤ 5.6%, n=18), pre diabetic patients (5.7% ≤ HbA1c ≤ 6.4%, n=36), and T2DM patients (HbA1c ≥ 6.5%, n=36) among individuals who meet the inclusion criteria and undergo annual physical examinations at the Physical Examination Center of the Third Hospital of Beijing Medical University. Collect the examination values related to demography and glucose metabolism balance of physical examination items, and carry out magnetic resonance imaging (MRI) imaging examination and oral glucose tolerance test (OGTT) results. Explore the high related factors of impaired glucose tolerance through descriptive statistics and analysis of variance. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03194152 -
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population
|
N/A | |
Enrolling by invitation |
NCT05760677 -
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
|
Phase 1 | |
Recruiting |
NCT04501341 -
BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06445335 -
Prevalence of NAFLD in T2DM Patients
|
N/A | |
Completed |
NCT03195400 -
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
|
||
Active, not recruiting |
NCT05662332 -
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
|
Phase 3 | |
Recruiting |
NCT05536804 -
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
|
Phase 2 | |
Completed |
NCT04011904 -
The Role of Traditional or Western Diet in the TBC1D4 Gene on Glucose Homeostasis in Greenland Inuits
|
N/A | |
Active, not recruiting |
NCT05260021 -
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
|
Phase 3 |